This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Dapagliflozin 5 mg tablets. The contract has a ceiling value of $1,631.11 and an ultimate completion date of September 19, 2024. It is a firm-fixed-price contract and does not have a set-aside designation.
The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Generated 12/18/24, 9:42 AM